Evaluating Payment Models for High-Cost Curative Therapies
The SOA is pleased to make available a research report that evaluates alternative payment models that potentially could be instituted by health care payers and manufacturers to pay for high-cost curative disease therapies and prescription drugs. The material was authored by a team from Milliman: Didier Serre, Joanne Buckle, Anne Jackson, and Jessica Naber.
The SOA would like to thank the following individuals for serving on the Project Oversight Group:
Steve Siegel, SOA Research Actuary
Barbara Scott, SOA Sr. Research Administrator
Questions Or Comments?
If you have comments or questions, please send an email to email@example.com.